Ebalzotan

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ebalzotan
Ebalzotan.png
Systematic (IUPAC) name
(3R)-N-(propan-2-yl)-3-[propan-2-yl(propyl)amino]-3,4-dihydro-2H-chromene-5-carboxamide
Clinical data
Legal status
  • Uncontrolled
Routes Oral
Identifiers
CAS number 149494-37-1
ATC code None
PubChem CID 9797080
ChemSpider 7972846
UNII WV4B56N49H YesY
Chemical data
Formula C19H30N2O2 
Mol. mass 318.45 g/mol

Ebalzotan (NAE-086) is a selective 5-HT1A receptor agonist.[1][2] It was under development as an antidepressant and anxiolytic agent but produced undesirable side effects in phase I clinical trials and was subsequently discontinued.[1][2]

See also[edit]

References[edit]

  1. ^ a b Tamim Braish; Gadamasetti, Kumar G. (2008). Process chemistry in the pharmaceutical industry, volume 2 challenges in an ever changing climate. Boca Raton: CRC Press. ISBN 0-8493-9051-6. 
  2. ^ a b Weaver, Donald F.; Nogrady, Thomas; Nogrady, Th (2005). Medicinal chemistry a molecular and biochemical approach. Oxford [Oxfordshire]: Oxford University Press. ISBN 0-19-510455-2.